Vulnerability Details : CVE-2010-1427
Cross-site scripting (XSS) vulnerability in the SearchHighlight plugin in MODx Evolution before 1.0.3 allows remote attackers to inject arbitrary web script or HTML via unknown vectors related to AjaxSearch.
Vulnerability category: Cross site scripting (XSS)
Products affected by CVE-2010-1427
- cpe:2.3:a:modxcms:evolution:*:*:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.6.2:*:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.0:*:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.6.1:p1:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.1:*:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.5:*:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.6:*:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.2.1:*:*:*:*:*:*:*
- cpe:2.3:a:modxcms:evolution:0.9.6.1:*:*:*:*:*:*:*
Exploit prediction scoring system (EPSS) score for CVE-2010-1427
0.25%
Probability of exploitation activity in the next 30 days
EPSS Score History
~ 64 %
Percentile, the proportion of vulnerabilities that are scored at or less
CVSS scores for CVE-2010-1427
| Base Score | Base Severity | CVSS Vector | Exploitability Score | Impact Score | Score Source | First Seen |
|---|---|---|---|---|---|---|
|
4.3
|
MEDIUM | AV:N/AC:M/Au:N/C:N/I:P/A:N |
8.6
|
2.9
|
NIST |
CWE ids for CVE-2010-1427
-
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.Assigned by: nvd@nist.gov (Primary)
References for CVE-2010-1427
-
https://exchange.xforce.ibmcloud.com/vulnerabilities/57635
MODx CMS unspecified cross-site scripting CVE-2010-1427 Vulnerability Report
-
http://jvn.jp/en/jp/JVN46669729/index.html
JVN#46669729 MODx vulnerable to cross-site scriptingPatch
-
http://jvndb.jvn.jp/ja/contents/2010/JVNDB-2010-000013.html
JVNDB-2010-000013 - JVN iPedia - 脆弱性対策情報データベースPatch
-
http://modxcms.com/forums/index.php/topic,47759.msg280304.html#msg280304
Security updates in MODx Evolution 1.0.3. You really should upgrade. | MODX Community ForumsPatch;Vendor Advisory
Jump to